Sandoz and mAbxience agree on emicizumab biosimilar partnership
Sandoz and mAbxience agree on emicizumab biosimilar partnership.
economy16 h ago
Yahoo FinanceRead original ↗
About
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis.
Source: Wikipedia (CC BY-SA)On coda.news
1 event, reported by media in 1 country
.svg?width=320){kind=logo}
.svg?width=320){kind=logo}
.svg?width=320)